The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
The FDA wants to pull its approval of a drug. It’s not so easy.
Source: Ars Technica
Original reporting
Ars Technica: read the full reportRelated stories
Wired
Spooky New Infostealer Malware Uses AI to ‘Autodox’ Victims
Named “Volta-Autodoxer,” the recently uncovered malware uses AI tools to collect troves of data about victims, from login credentials and credit card numbers to Discord sessions and UberEats receipts.
The Verge
Touchscreens everywhere!
Hi, friends! Welcome to Installer No. 150, your guide to the best and Verge-iest stuff in the world. (If you're new here, welcome, happy Halloween, and also you can read all the old editions at the Installer homepage.) This week, I was in the Smoky Mountains in Tennessee on a family vacation. It was delightful […]
The Verge
Here’s why you can’t shake those unhinged political texts
"Its James Talarico. Can you please please please please pretty pretty please rush in even just $1?" "Who's working to elect James Talarico? Marxists." "Wow! Wow! Wow! Mark Kelly just made a HUGE announcement!" "We asked Ben Verlander, MLB analyst and former Tigers prospect, to record a quick video about the election this Tuesday, November […]
Ars Technica
Seabirds racing home over the ocean can get jet-lagged
A long flight home from feeding grounds messes with birds' internal clocks.
Wired
Meta’s Muse Could Upend All Kinds of Businesses. It Hasn’t Yet
Companies have spent the past several weeks trying to reassure investors that Muse and other AI agents pose more of an opportunity than a threat.
Wired
An AI Agent Injected Drugs Into a Live Mouse’s Brain
A biotech startup let an agent choose a gene therapy and successfully inject the treatment, offering a startling glimpse of the future of research labs.